These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24721216)
1. Comparison of fecal occult blood tests for colorectal cancer screening in an Alaska Native population with high prevalence of Helicobacter pylori infection, 2008-2012. Redwood D; Provost E; Asay E; Roberts D; Haverkamp D; Perdue D; Bruce MG; Sacco F; Espey D Prev Chronic Dis; 2014 Apr; 11():E56. PubMed ID: 24721216 [TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test. Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078 [TBL] [Abstract][Full Text] [Related]
4. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests. Meklin J; SyrjÄnen K; Eskelinen M Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599 [TBL] [Abstract][Full Text] [Related]
5. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis. Zhu MM; Xu XT; Nie F; Tong JL; Xiao SD; Ran ZH J Dig Dis; 2010 Jun; 11(3):148-60. PubMed ID: 20579218 [TBL] [Abstract][Full Text] [Related]
6. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Smith A; Young GP; Cole SR; Bampton P Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938 [TBL] [Abstract][Full Text] [Related]
7. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper. Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704 [TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal neoplasias with fecal occult blood tests: false-positive impact of non-dietary restriction. Roslani AC; Abdullah T; Arumugam K Asian Pac J Cancer Prev; 2012; 13(1):237-41. PubMed ID: 22502676 [TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know. Tinmouth J; Lansdorp-Vogelaar I; Allison JE Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients. Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467 [TBL] [Abstract][Full Text] [Related]
11. Colon cancer screening: which non-invasive filter tests? Pox C Dig Dis; 2011; 29 Suppl 1():56-9. PubMed ID: 22104755 [TBL] [Abstract][Full Text] [Related]
12. Replacing the Guaiac Fecal Occult Blood Test With the Fecal Immunochemical Test Increases Proportion of Individuals Screened in a Large Healthcare Setting. Akram A; Juang D; Bustamante R; Liu L; Earles A; Ho SB; Wang-Rodriguez J; Allison JE; Gupta S Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1265-1270.e1. PubMed ID: 28167157 [TBL] [Abstract][Full Text] [Related]
13. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening. Chausserie S; Levillain R; Puvinel J; Ferrand O; Ruiz A; Raginel T; Lantieri O; Launoy G; Guittet L Int J Cancer; 2015 Apr; 136(8):1827-34. PubMed ID: 25195670 [TBL] [Abstract][Full Text] [Related]
14. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128 [TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016. Almansoori A; Alzaabi M; Alketbi L BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343 [TBL] [Abstract][Full Text] [Related]
16. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results. Brenner H; Hoffmeister M; Birkner B; Stock C Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771 [TBL] [Abstract][Full Text] [Related]
17. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening. Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896 [TBL] [Abstract][Full Text] [Related]
18. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Lohsiriwat V; Thavichaigarn P; Awapittaya B J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309 [TBL] [Abstract][Full Text] [Related]
19. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415 [TBL] [Abstract][Full Text] [Related]